Heart FailureNCT06540118
Food Is Medicine for Patients With Heart Failure
A study testing 15 Medically Tailored Meals (MTM) per week and 14 Medically Tailored Meals (MTM) per week in people with Heart Failure and Heart Failure,Congestive, run by University of California, San Diego at 2 sites in United States.
Trial summary
This study will look at the effects of providing medically tailored meals (MTMs) to people with heart disease for twelve weeks. The primary outcome of the study is the quality of the diet being consumed in week 12 of the study, as determined by the "Healthy Eating Index." Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Heart Failure, Heart Failure,Congestive, Heart Diseases
- What is being tested?
- 15 Medically Tailored Meals (MTM) per week and 14 Medically Tailored Meals (MTM) per week
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 2 sitesUnited States
- Study dates
- 17 Oct 2024to 28 Jul 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Willingness to comply with all study procedures and availability for the duration of the study
- Living in San Diego or the Bay Area of California
- Reported congestive heart failure (CHF) diagnosis
- Current diet can be improved
- Willing to eat all meals provided by the study
Who cannot join
- Diagnosed with end-stage heart failure
- Diagnosed with diabetes (type 1 or uncontrolled type 2)
- Currently taking insulin and/or meglitinides medications
- Currently taking Glucagon-Like Peptide-1 (GLP-1) Agonists medications and not stable on a maximum maintenance dose for a minimum of 1 month
- Hemoglobin A1c (HbA1c) results >8 %
- Life expectancy of <1 year
Show all 12Show fewer
- Pregnancy or lactation
- Known severe allergic reactions and/or food intolerances that would interfere with the ability to eat study-provided meals, including foods that are prepared in a facility that works with the allergen
- Current smoker or tobacco use within the past year
- Planning to leave San Diego or the Bay Area during the course of the study
- Unable to communicate reasonably well either orally or through written material in English
- Those who, in the opinion of the investigators, cannot reliably complete the study protocol
Trial locations and contacts
2 sites in 1 country.
United States2 sites
University of California San Diego
La Jolla, California, 92093
Stanford University
Stanford, California, 94305
About this study
This study will look at the effects of providing medically tailored meals (MTMs) to people with heart disease for twelve weeks. The primary outcome of the study is the quality of the diet being consumed in week 12 of the study, as determined by the "Healthy Eating Index."
Read the detailed description
This study will look at the effects of providing medically tailored meals (MTMs) to people with heart disease for twelve weeks. Sixty adults with heart failure will be recruited from the San Diego and San Francisco Bay Area of California. They will be randomly assigned to two groups: 1) a group that receives 15 "medically tailored meals" plus snacks each week for 12 weeks, 2) a group that receives 14 "medically tailored meals" each week for 12 weeks. The primary outcome of the study is the quality of the diet being consumed in week 12 of the study, as determined by the "Healthy Eating Index". Many other secondary outcomes will be assessed including both qualitative factors (e.g., satisfaction, preferences, adherence) and quantitative clinically measures (e.g., blood cholesterol, blood pressure, weight).
- Conditions
- Heart Failure, Heart Failure,Congestive, Heart Diseases
- Being tested
- 15 Medically Tailored Meals (MTM) per week, 14 Medically Tailored Meals (MTM) per week
- Medical subject headings
- Heart Failure, Heart Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
15 Medically Tailored Meals (MTM) per weekOther
15 heart-healthy medically tailored meals delivered to participants each week. Meals include breakfast, lunch, dinner, and snack to consume Monday-Friday.
14 Medically Tailored Meals (MTM) per weekOther
14 heart-healthy medically tailored meals delivered to participants each week. Meals include lunch and dinner to consume Monday-Sunday.
| Study group | Role | What they receive |
|---|---|---|
| 15 Medically Tailored Meals (MTM) + snacks | Experimental | Participants will receive 15 medically tailored meals (MTM) per week, plus snacks, for 12 weeks. Receives: Other: 15 Medically Tailored Meals (MTM) per week |
| 14 Medically Tailored Meals (MTM) | Experimental | Participants will receive 14 medically tailored meals (MTM) per week for 12 weeks. Receives: Other: 14 Medically Tailored Meals (MTM) per week |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in diet quality at Week 12, as determined by the Healthy Eating Index (HEI)
HEI will be used to determine diet quality based on dietary recall data collected via Nutrition Data System for Research (NDSR) software. HEI scores range from 0 to 100. An ideal overall HEI score of 100 reflects that the set of foods aligns with key dietary recommendations and dietary patterns published in the Dietary Guidelines for Americans.
Measured: Baseline and Week 12
Secondary outcomes (9)
Participant satisfaction with delivery of medically tailored meals for individuals with heart failure
Participant satisfaction will be assessed using a study-specific self-administered questionnaire that uses a 5-point Likert scale. Participants will be asked to rate their experiences with multiple aspects of the provided study meals (including taste, variety, quality, cultural appropriateness, amount of food, visual appeal, and delivery) from "poor" to "excellent".
Measured: Week 4 and Week 12
Dietary adherence to meal assignment using daily food diaries and 24-hour dietary recalls
Participants' qualitative daily food diaries and quantitative dietary analyses based on interviewer-assisted dietary recalls using Nutrition Data System for Research (NDSR) software will be combined to determine the proportion of provided meals that participants consumed.
Measured: Baseline and Weeks 4, 6, 8, and 12
Change in reported access to healthy foods as assessed by the Food Consumption Score (FCS)
The Food Consumption Score aggregates household-level data on the diversity and frequency of food groups consumed over the previous seven days, which is then weighted according to the relative nutritional value of the consumed food groups. The Food Consumption Score scale ranges from 0-112, with higher scores indicating better food consumption status.
Measured: Baseline, Week 12, and Week 24
Change in reported food security as assessed by the Food Insecurity Experience Scale (FIES)
The Food Insecurity Experience Scale (FIES) consists of eight questions regarding people's access to adequate food during the last 30 days. The raw score scale ranges from 0-8, with a higher score indicating more food insecurity experiences. Scale items are analyzed together as a scale, not be reported in terms of percent of positive responses to individual questions. The classifications of food insecurity severity based on responses may be described as mild, moderate, and severe food insecurity.
Measured: Baseline, Week 12, Week 24
Change in reported food security as assessed by the Short Form of the U.S. Adult Food Security Survey Module
The 6-item survey collects information about whether participants had access to and were able to afford enough food in the last 30 days. The survey allows for stratification of participants into one of four food security categories based on their responses - high food security, marginal food security, low food security, and very low food security. The raw score scale ranges from 0 - 6, with a higher score indicating lower food security.
Measured: Baseline, Week 12, Week 24
Change in mean blood pressure
Mean blood pressure will be calculated based on 3 consecutive readings in the research clinic during each in-person study visit.
Measured: Baseline and Week 12
Change in blood lipid levels
Measured: Baseline and Week 12
Change in Hemoglobin A1C (HbA1C) levels
Measured: Baseline and Week 12
Change in weight
Weight will be measured by study personnel at each in-person study visit.
Measured: Baseline and Week 12
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Aug 2024
- Study start17 Oct 2024
- Primary completion28 Jul 2025
- Study completion28 Jul 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Heart FailureStudies of the same condition, open and under way.
- More trials run by University of California, San DiegoThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of California, San Diego
- Sponsor type
- University, hospital or other
- Collaborators
- Stanford University
- Responsible party
- Principal investigator, Cheryl A. Anderson, MPH, PhD, University of California, San Diego
- Investigators
- Cheryl Anderson, PhD, MPH, MS, Principal investigator, UC San DiegoChristopher Gardner, PhD, Principal investigator, Stanford University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06540118
- Sponsor's protocol ID
- 24RPGFIM1198191
- Status last verified
- Jan 2026
- First submitted
- 24 Jul 2024
- Last updated
- 26 Jan 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Food Is Medicine for Patients With Heart Failure
- ClinicalTrials.gov ID
- NCT06540118
- Acronym / sponsor ID
- 24RPGFIM1198191
- Conditions
- Heart Failure, Heart Failure,Congestive, Heart Diseases
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- University of California, San DiegoUniversity, hospital or other
- Collaborators
- Stanford University
- Study start
- 17 Oct 2024 (actual)
- Primary completion
- 28 Jul 2025 (actual)
- Study completion
- 28 Jul 2025 (actual)
- First posted
- 6 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will look at the effects of providing medically tailored meals (MTMs) to people with heart disease for twelve weeks. The primary outcome of the study is the quality of the diet being consumed in week 12 of the study, as determined by the "Healthy Eating Index."
Detailed description
This study will look at the effects of providing medically tailored meals (MTMs) to people with heart disease for twelve weeks. Sixty adults with heart failure will be recruited from the San Diego and San Francisco Bay Area of California. They will be randomly assigned to two groups: 1) a group that receives 15 "medically tailored meals" plus snacks each week for 12 weeks, 2) a group that receives 14 "medically tailored meals" each week for 12 weeks. The primary outcome of the study is the quality of the diet being consumed in week 12 of the study, as determined by the "Healthy Eating Index". Many other secondary outcomes will be assessed including both qualitative factors (e.g., satisfaction, preferences, adherence) and quantitative clinically measures (e.g., blood cholesterol, blood pressure, weight).
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| 15 Medically Tailored Meals (MTM) + snacks | Experimental | Other: 15 Medically Tailored Meals (MTM) per weekParticipants will receive 15 medically tailored meals (MTM) per week, plus snacks, for 12 weeks. |
| 14 Medically Tailored Meals (MTM) | Experimental | Other: 14 Medically Tailored Meals (MTM) per weekParticipants will receive 14 medically tailored meals (MTM) per week for 12 weeks. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Willingness to comply with all study procedures and availability for the duration of the study
- Living in San Diego or the Bay Area of California
- Reported congestive heart failure (CHF) diagnosis
- Current diet can be improved
- Willing to eat all meals provided by the study
Key exclusion criteria (12 listed)
- Diagnosed with end-stage heart failure
- Diagnosed with diabetes (type 1 or uncontrolled type 2)
- Currently taking insulin and/or meglitinides medications
- Currently taking Glucagon-Like Peptide-1 (GLP-1) Agonists medications and not stable on a maximum maintenance dose for a minimum of 1 month
- Hemoglobin A1c (HbA1c) results >8 %
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| 15 Medically Tailored Meals (MTM) per week15 heart-healthy medically tailored meals delivered to participants each week. Meals include breakfast, lunch, dinner, and snack to consume Monday-Friday. | Other | 15 Medically Tailored Meals (MTM) + snacks |
| 14 Medically Tailored Meals (MTM) per week14 heart-healthy medically tailored meals delivered to participants each week. Meals include lunch and dinner to consume Monday-Sunday. | Other | 14 Medically Tailored Meals (MTM) |
Primary outcome
Change in diet quality at Week 12, as determined by the Healthy Eating Index (HEI)
Time frame: Baseline and Week 12
HEI will be used to determine diet quality based on dietary recall data collected via Nutrition Data System for Research (NDSR) software. HEI scores range from 0 to 100. An ideal overall HEI score of 100 reflects that the set of foods aligns with key dietary recommendations and dietary patterns published in the Dietary Guidelines for Americans.
9 secondary outcomes
Participant satisfaction with delivery of medically tailored meals for individuals with heart failure
Time frame: Week 4 and Week 12
Dietary adherence to meal assignment using daily food diaries and 24-hour dietary recalls
Time frame: Baseline and Weeks 4, 6, 8, and 12
Change in reported access to healthy foods as assessed by the Food Consumption Score (FCS)
Time frame: Baseline, Week 12, and Week 24
Change in reported food security as assessed by the Food Insecurity Experience Scale (FIES)
Time frame: Baseline, Week 12, Week 24
Change in reported food security as assessed by the Short Form of the U.S. Adult Food Security Survey Module
Time frame: Baseline, Week 12, Week 24
Change in mean blood pressure
Time frame: Baseline and Week 12
Change in blood lipid levels
Time frame: Baseline and Week 12
Change in Hemoglobin A1C (HbA1C) levels
Time frame: Baseline and Week 12
Change in weight
Time frame: Baseline and Week 12
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jan 2026.
- Individual participant dataSharing planned: No
Related trials for Heart Failure
RecruitingPhase 4
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
Heart Failure With Reduced Ejection Fraction, Iron Deficiency
Not yet recruitingPhase 2
A Study of Bimagrumab in Participants With HFpEF
Heart Failure, Diastolic, Diastolic Heart Failure
Recruiting
Evaluation of a French Hospital Discharge Therapeutic Education Program by Nurses for Heart Failure Patient (EduSor)
Heart Failure
Active, not recruiting
Assessment of Combined CCM and ICD Device in HFrEF
Heart Failure, Heart Failure With Reduced Ejection Fraction
Not yet recruiting
RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF
Heart Failure and Reduced Ejection Fraction, Heart Failure Chronic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Cheryl Anderson, PhD, MPH, MS principal investigator
UC San Diego
Christopher Gardner, PhD principal investigator
Stanford University
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing 15 Medically Tailored Meals (MTM) per week and 14 Medically Tailored Meals (MTM) per week in people with Heart Failure and Heart Failure,Congestive, run by University of California, San Diego at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in diet quality at Week 12, as determined by the Healthy Eating Index (HEI) (time frame: Baseline and Week 12). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2026.